Literature DB >> 11869683

Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation.

Atsushi Mizoguchi1, Emiko Mizoguchi, Hidetoshi Takedatsu, Richard S Blumberg, Atul K Bhan.   

Abstract

B cells possess a variety of immune functions that are involved in normal and abnormal immune responses, including autoimmune disorders. Through murine models of intestinal inflammation, we here demonstrate a B cell subset that is induced in gut-associated lymphoid tissues and is characterized by CD1d upregulation. This B cell subset appears under a chronic inflammatory environment, produces IL-10, and suppresses progression of intestinal inflammation by downregulating inflammatory cascades associated with IL-1 upregulation and STAT3 activation rather than by altering polarized T helper responses. This study indicates that B cells, by producing cytokines such as IL-10, can act as regulatory cells in immunologically mediated inflammatory reactions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11869683     DOI: 10.1016/s1074-7613(02)00274-1

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  342 in total

1.  Regulatory B cells that produce IL-10: a breath of fresh air in allergic airway disease.

Authors:  Thomas F Tedder; Takashi Matsushita
Journal:  J Allergy Clin Immunol       Date:  2010-05       Impact factor: 10.793

2.  A novel mechanism of B cell-mediated immune suppression through CD73 expression and adenosine production.

Authors:  Hiroaki Kaku; Kai Fan Cheng; Yousef Al-Abed; Thomas L Rothstein
Journal:  J Immunol       Date:  2014-11-12       Impact factor: 5.422

3.  B cell depletion therapy exacerbates murine primary biliary cirrhosis.

Authors:  Amy Dhirapong; Ana Lleo; Guo-Xiang Yang; Koichi Tsuneyama; Robert Dunn; Marilyn Kehry; Thomas A Packard; John C Cambier; Fu-Tong Liu; Keith Lindor; Ross L Coppel; Aftab A Ansari; M Eric Gershwin
Journal:  Hepatology       Date:  2010-12-28       Impact factor: 17.425

4.  Come forth CD1d: Hsp110 in the regulation of intestinal epithelial CD1d expression.

Authors:  Christopher V Nicchitta
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

5.  Reduced ratio of protective versus proinflammatory cytokine responses to commensal bacteria in HLA-B27 transgenic rats.

Authors:  L A Dieleman; F Hoentjen; B-F Qian; D Sprengers; E Tjwa; M F Torres; C D Torrice; R B Sartor; S L Tonkonogy
Journal:  Clin Exp Immunol       Date:  2004-04       Impact factor: 4.330

Review 6.  Regulatory B cells in autoimmunity: developments and controversies.

Authors:  Claudia Mauri; Paul A Blair
Journal:  Nat Rev Rheumatol       Date:  2010-09-21       Impact factor: 20.543

Review 7.  The double life of a B-1 cell: self-reactivity selects for protective effector functions.

Authors:  Nicole Baumgarth
Journal:  Nat Rev Immunol       Date:  2010-12-10       Impact factor: 53.106

Review 8.  Animal models of IBD: linkage to human disease.

Authors:  Atsushi Mizoguchi; Emiko Mizoguchi
Journal:  Curr Opin Pharmacol       Date:  2010-06-08       Impact factor: 5.547

Review 9.  Genetically engineered mouse models for studying inflammatory bowel disease.

Authors:  Atsushi Mizoguchi; Takahito Takeuchi; Hidetomo Himuro; Toshiyuki Okada; Emiko Mizoguchi
Journal:  J Pathol       Date:  2015-11-14       Impact factor: 7.996

Review 10.  CEACAM1 and the regulation of mucosal inflammation.

Authors:  T Nagaishi; Z Chen; L Chen; H Iijima; A Nakajima; R S Blumberg
Journal:  Mucosal Immunol       Date:  2008-11       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.